Key result
Preoperative high depression was associated with significantly higher mortality after heart transplantation in patients with ischemic cardiomyopathy.
Why the study?
Does preoperative high depression increase mortality in patients undergoing heart transplantation?
Cohort (n=152)
Does preoperative high depression increase mortality in patients undergoing heart transplantation?
Preoperative self-reported depression is associated with higher postoperative mortality in patients with ischemic cardiomyopathy undergoing heart transplantation.
May warrant preoperative depression screening in ischemic cardiomyopathy transplant candidates; leaves open whether intervention improves survival.
OBJECTIVE: This study explored the value of preoperative self-reported assessment for depression and anxiety in patients who had undergone heart transplantation (HTx). The initial sample was divided into subgroups of patients with ischemic (ICMP) and dilated cardiomyopathy (DCMP). Patient depression and anxiety scores were measured in both subgroups and their impact on pre- and postoperative mortality investigated. METHOD: An initial sample of 152 patients with either ICMP (N = 57) or DCMP (N = 95) and end-stage heart disease awaiting heart transplantation were assessed in a multidimensional longitudinal study, including psychological and somatic variables. One hundred and three patients received a HTx and were followed up for a mean of 4.4 years. Proportional hazard models were computed to test for the influence of psychosocial and somatic factors on outcome. RESULTS: Preoperative depression and state anxiety scores were significantly higher in the ICMP group. In addition to donor and recipient age, ICMP patients in the preoperative high depression group also showed a significantly higher mortality after HTx. This result remained significant even after controlling for sociodemographic and somatic variables. CONCLUSIONS: Patient self-reported depression, but not anxiety, can contribute to the identification of subgroups of patients with an unfavorable outcome after HTx. It therefore may be helpful to screen for depression, particularly in patients with an ischemic cause of their end-stage heart disease. Specific intervention programs should be further developed and evaluated.
No takes yet. Share an insight, caveat, or question.
Stephan Zipfel (2002) conducted a cohort in End-stage heart disease (n=152). Preoperative depression vs. Lower preoperative depression was evaluated on Mortality after heart transplantation. Preoperative high depression was associated with significantly higher mortality after heart transplantation in patients with ischemic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: